All Stories

  1. Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals
  2. Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease
  3. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease
  4. Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet–Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents
  5. Gastric bypass–induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers
  6. Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo
  7. OR024: Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia
  8. The Kidney
  9. Carnitine in Maintenance Hemodialysis Patients
  10. OP036: Circulating Fatty Acids are Associated with Acyl- and Desacyl-Ghrelin Balance in Humans
  11. The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study
  12. Carnitine metabolism and nutrition in dialysis patients
  13. Carnitine metabolism and nutrition in peripheral arterial disease
  14. Acylated ghrelin limits fat accumulation and improves redox state and inflammation markers in the liver of high-fat-fed rats
  15. Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome
  16. Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome
  17. Ghrelin and Muscle Metabolism in Chronic Uremia
  18. Hemodialysis Induces p66shc Gene Expression in Nondiabetic Humans: Correlations with Oxidative Stress and Systemic Inflammation
  19. Fighting Protein-Energy Wasting in Chronic Kidney Disease: A Challenge of Complexity
  20. Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta
  21. Metabolic Syndrome and Chronic Kidney Disease
  22. Insulin Resistance in Chronic Uremia
  23. Whey Protein Ingestion Enhances Postprandial Anabolism during Short-Term Bed Rest in Young Men
  24. Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis
  25. Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients
  26. Inflammation and Insulin Resistance in Uremia
  27. Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment
  28. Vascular Sources of Oxidative Stress: Implications for Uremia-Related Cardiovascular Disease
  29. Advances in Carnitine in Chronic Uremia
  30. Inflammation and Adipose Tissue in Uremia
  31. Guest editorial
  32. Metabolic effects of ghrelin and its potential implications in uremia
  33. The impact of inflammation on metabolic regulation in chronic kidney disease: A review
  34. Myostatin expression is not altered by insulin deficiency and replacement in streptozotocin-diabetic rat skeletal muscles
  35. Chronic systemic inflammation in uremia: Potential therapeutic approaches
  36. Update on Hospital Malnutrition
  37. Guest editorial
  38. Guest editorial
  39. Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats
  40. Mechanisms of malnutrition in uremia
  41. Mechanisms of altered protein turnover in chronic diseases: a review of human kinetic studies
  42. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients
  43. Regulation of muscle cathepsin B proteolytic activity in protein-depleted patients with chronic diseases
  44. Carnitine metabolism in uremia
  45. Slower activation of insulin action in upper body obesity
  46. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients
  47. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients
  48. P42 Atherosclerosis and inflammation, cytokine regulation in patients with peripheral arterial disease
  49. P44 Slower activation of insulin action in the hypertension of obesity: Relationship with abdominal fat deposition
  50. P62 Antiplatelet therapy in patients with lower limbs arteriopathy: A 10-year prospective study
  51. Molecular regulation of protein catabolism in trauma patients
  52. Slower activation of insulin action in hypertension associated with obesity
  53. O.65 Kinetics of insulin action in obesity: relationship with abdominal fat deposition
  54. Amino acid and protein therapy in chronic renal failure
  55. Relationship between Whole-Body Protein Turnover and Serum Creatinine in Chronically Uremic Patients
  56. Metabolism after Injury: The Effects of G.H.
  57. Metabolic response to injury and sepsis: changes in protein metabolism
  58. The Assessment of Nutritional State
  59. Cathepsin B and D Activity in Human Skeletal Muscle in Disease States
  60. Nutritional Assessment in Hospital Malnutrition
  61. Plasma and muscle carnitine in experimental uremia
  62. Influence of kidney transplantation on carnitine metabolism
  63. Acetate Intolerance in Chronic Uremic Patients
  64. Effects of L-Carnitine Supplementation in the Dialysate on Serum Lipoprotein Composition of Hemodialysis Patients1
  65. Effects of Erythropoietin Administration on Nutritional State and Erythrocyte Metabolism in Maintenance Hemodialysis Patients